Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | PARP1 | P09874 | 1/20 | 0.54 |
| ▸ | AURKA | O14965 | 1/20 | 0.42 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.42 |
| ▸ | NOS2 | P35228 | 3/20 | 0.38 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.37 |
| ▸ | NOS1 | P29475 | 2/20 | 0.37 |
| ▸ | NOS3 | P29474 | 1/20 | 0.37 |
| ▸ | DRD2 | P14416 | 1/20 | 0.35 |
| ▸ | NR3C1 | P04150 | 2/20 | 0.35 |
| ▸ | PGR | P06401 | 2/20 | 0.35 |
| ▸ | NR3C2 | P08235 | 2/20 | 0.35 |
| ▸ | AR | P10275 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | HTR5A | P47898 | 1/20 | 0.34 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18271938 | 1.00 | LMNA (0.56) | LMNATSHRPARP1AURKAAURKB | |
| SCHEMBL29386048 | 1.00 | LMNA (0.56) | LMNATSHRPARP1AURKAAURKB | |
| SCHEMBL18269673 | 1.00 | LMNA (0.56) | LMNATSHRPARP1AURKAAURKB | |
| SCHEMBL18324161 | 1.00 | LMNA (0.56) | LMNATSHRPARP1AURKAAURKB | |
| SCHEMBL4498580 | 0.96 | LMNA (0.61) | LMNATSHRPARP1AURKAAURKB | |
| SCHEMBL9120552 | 0.96 | LMNA (0.61) | LMNATSHRPARP1AURKAAURKB | |
| SCHEMBL11304909 | 0.96 | LMNA (0.61) | LMNATSHRPARP1AURKAAURKB | |
| SCHEMBL30372866 | 0.96 | LMNA (0.61) | LMNATSHRPARP1AURKAAURKB | |
| SCHEMBL18269675 | 0.96 | LMNA (0.61) | LMNATSHRPARP1AURKAAURKB | |
| SCHEMBL21077720 | 0.94 | LMNA (0.59) | LMNATSHRPARP1AURKAAURKB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4284144-A1 | LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE SAME | Samsung Display Co., Ltd. (KR) | 2023-11-29 | — | — | EP | disclosed |
| CN-117119821-A | Light-emitting element, electronic device including the same, and electronic apparatus | 三星显示有限公司 | 2023-11-24 | — | — | CN | disclosed |
| US-20230380262-A1 | LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-11-23 | — | — | US | disclosed |
| US-20230134849-A1 | PHOTOELECTRIC CONVERSION ELEMENT, PHOTOELECTRIC CONVERSION MODULE, AND ELECTRONIC DEVICE | RICOH COMPANY, LTD. (JP) | 2023-05-04 | — | — | US | disclosed |
| US-20230134849-A1 | PHOTOELECTRIC CONVERSION ELEMENT, PHOTOELECTRIC CONVERSION MODULE, AND ELECTRONIC DEVICE | RICOH COMPANY, LTD. (JP) | 2023-05-04 | — | — | US | disclosed |
| CN-114031547-A | Indole compound and application thereof | 上海甘田光学材料有限公司 | 2022-02-11 | — | — | CN | disclosed |
| US-9748044-B2 | Photosensitizer and photoelectric conversion device | CHEMICREA INC. (JP) | 2017-08-29 | — | — | US | disclosed |
| US-9748044-B2 | Photosensitizer and photoelectric conversion device | CHEMICREA INC. (JP) | 2017-08-29 | — | — | US | disclosed |
| US-9697956-B2 | Diketopyrrolopyrole (DPP)-based sensitizers for electrochemical or optoelectronic devices | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) | 2017-07-04 | — | — | US | disclosed |
| US-9697956-B2 | Diketopyrrolopyrole (DPP)-based sensitizers for electrochemical or optoelectronic devices | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) | 2017-07-04 | — | — | US | disclosed |
| US-7141563-B2 | Process for the preparation of 1, 2, 3, 4, 8, 9, 10, 10a-octahydro-7bH-cyclopenta[b] [1, 4]diazepino[6, 7, 1-hi] indole derivatives | WYETH (US) | 2006-11-28 | — | — | US | disclosed |
| US-20050004101-A1 | Cyclopenta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives | WYETH (US) | 2005-01-06 | — | — | US | disclosed |
| EP-1330457-B1 | CYCLOPENTA[B][1,4] DIAZEPINO[6,7,1-HI]INDOLES AS 5HT2C ANTAGONISTS | WYETH CORP (US) | 2004-10-20 | — | — | EP | disclosed |
| US-6777407-B2 | 7BH-CYCLOPENTA(B)(1,4)DIAZEPINO(6, 7, 1-HI)INDOLE OR A SALT, USEFUL FOR TREATMENT OF SCHIZOPHRENIA, OBSESSIVE COMPULSIVE DISORDER, DEPRESSION, ANXIETY, PANIC DISORDER, OBESITY OR EPILEPSY | WYETH | 2004-08-17 | — | — | US | disclosed |
| US-6777407-B2 | 7BH-CYCLOPENTA(B)(1,4)DIAZEPINO(6, 7, 1-HI)INDOLE OR A SALT, USEFUL FOR TREATMENT OF SCHIZOPHRENIA, OBSESSIVE COMPULSIVE DISORDER, DEPRESSION, ANXIETY, PANIC DISORDER, OBESITY OR EPILEPSY | WYETH | 2004-08-17 | — | — | US | disclosed |
| EP-1330457-A2 | CYCLOPENTA[B][1,4] DIAZEPINO[6,7,1-HI]INDOLES AS 5HT2C ANTAGONISTS | Wyeth (US) | 2003-07-30 | — | — | EP | disclosed |
| US-20020107242-A1 | Cyclopenta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives | AMERICAN HOME PRODUCTS CORPORATION | 2002-08-08 | — | — | US | disclosed |
| WO-2002042304-A2 | CYCLOPENTA[B][1,4] DIAZEPINO[6,7,1-HI]INDOLES AS 5HT2C ANTAGONISTS | WYETH (US) | 2002-05-30 | — | — | WO | disclosed |
| US-20020058689-A1 | Process for the preparation of 1, 2, 3, 4, 8, 9, 10, 10a-octahydro-7bH-cyclopenta[b] [1, 4]diazepino[6, 7, 1-hi]indole derivatives | AMERICAN HOME PRODUCTS CORPORATION (US) | 2002-05-16 | — | — | US | disclosed |
| US-4755505-A | 1-[2-(dialkylamino)alkyl]-4,5-dihydro-4-(aryl)-1-benzazocine-2,6(1H,3H)-diones as anti-arrhythmic agents | AMERICAN HOME PRODUCTS CORPORATION (US) | 1988-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020107242-A1 | Cyclopenta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives | CNR1, HCRTR1, HTR3C | LMNA 3061/4885TSHR 481/4885PARP1 1209/4885 |
| US-20020058689-A1 | Process for the preparation of 1, 2, 3, 4, 8, 9, 10, 10a-octahydro-7bH-cyclopenta[b] [1, 4]diazepino[6, 7, 1-hi]indole derivatives | HRH3, HTR1A, HTR7 | LMNA 3537/4885TSHR 378/4885PARP1 730/4885 |
| US-20050004101-A1 | Cyclopenta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives | CNR1, HCRTR1, HTR3C | LMNA 3207/4885TSHR 371/4885PARP1 1515/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.